Analyst Expect Big Moves From Galmed Pharmaceuticals Ltd (NASDAQ: GLMD)
Currently, there are 2.26M common shares owned by the public and among those 2.22M shares have been available to trade. The company’s stock has a 5-day price change of 19.29% and -41.61% over the past three months. GLMD shares are trading -47.65% year to date (YTD), with the 12-month market performance down to -65.21% lower. […]
Galmed Pharmaceuticals Ltd (GLMD) Volatility Spurs A Quest For Clarity
Currently, there are 1.66M common shares owned by the public and among those 1.63M shares have been available to trade. The company’s stock has a 5-day price change of 31.93% and -13.19% over the past three months. GLMD shares are trading -21.63% year to date (YTD), with the 12-month market performance down to -42.05% lower. […]
